Literature DB >> 22077150

Hdac-mediated control of endochondral and intramembranous ossification.

Elizabeth W Bradley1, Meghan E McGee-Lawrence, Jennifer J Westendorf.   

Abstract

Histone deacetylases (Hdacs) remove acetyl groups (CH3CO-) from ε-amino groups in lysine residues within histones and other proteins. This posttranslational (de) modification alters protein stability, protein-protein interactions, and chromatin structure. Hdac activity plays important roles in the development of all organs and tissues, including the mineralized skeleton. Bone is a dynamic tissue that forms and regenerates by two processes: endochondral and intramembranous ossification. Chondrocytes and osteoblasts are responsible for producing the extracellular matrices of skeletal tissues. Several Hdacs contribute to the molecular pathways and chromatin changes that regulate tissue-specific gene expression during chondrocyte and osteoblast specification, maturation, and terminal differentiation. In this review, we summarize the roles of class I and class II Hdacs in chondrocytes and osteoblasts. The effects of small molecule Hdac inhibitors on the skeleton are also discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22077150      PMCID: PMC3218555          DOI: 10.1615/critreveukargeneexpr.v21.i2.10

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  101 in total

1.  Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells.

Authors:  Giovanni Di Bernardo; Nicola Alessio; Carmela Dell'Aversana; Fiorina Casale; Diana Teti; Marilena Cipollaro; Lucia Altucci; Umberto Galderisi
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

2.  HDAC3 is negatively regulated by the nuclear protein DBC1.

Authors:  Claudia C S Chini; Carlos Escande; Veronica Nin; Eduardo N Chini
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

3.  Phosphorylation of RUNX1 by cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3.

Authors:  Hong Guo; Alan D Friedman
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

4.  The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss.

Authors:  Jitesh Pratap; Jacqueline Akech; John J Wixted; Gabriela Szabo; Sadiq Hussain; Meghan E McGee-Lawrence; Xiaodong Li; Krystin Bedard; Robinder J Dhillon; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jennifer J Westendorf; Jane B Lian
Journal:  Mol Cancer Ther       Date:  2010-12       Impact factor: 6.261

5.  Endocrine regulation of male fertility by the skeleton.

Authors:  Franck Oury; Grzegorz Sumara; Olga Sumara; Mathieu Ferron; Haixin Chang; Charles E Smith; Louis Hermo; Susan Suarez; Bryan L Roth; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2011-02-17       Impact factor: 41.582

6.  Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems.

Authors:  Stephen R Williams; Micheala A Aldred; Vazken M Der Kaloustian; Fahed Halal; Gordon Gowans; D Ross McLeod; Sara Zondag; Helga V Toriello; R Ellen Magenis; Sarah H Elsea
Journal:  Am J Hum Genet       Date:  2010-08-13       Impact factor: 11.025

7.  Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes.

Authors:  Diego Correa; Eric Hesse; Dutmanee Seriwatanachai; Riku Kiviranta; Hiroaki Saito; Kei Yamana; Lynn Neff; Azeddine Atfi; Lucie Coillard; Despina Sitara; Yukiko Maeda; Soren Warming; Nancy A Jenkins; Neal G Copeland; William C Horne; Beate Lanske; Roland Baron
Journal:  Dev Cell       Date:  2010-10-19       Impact factor: 12.270

8.  Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity.

Authors:  Eric Hesse; Hiroaki Saito; Riku Kiviranta; Diego Correa; Kei Yamana; Lynn Neff; Daniel Toben; Georg Duda; Azeddine Atfi; Valérie Geoffroy; William C Horne; Roland Baron
Journal:  J Cell Biol       Date:  2010-12-20       Impact factor: 10.539

9.  The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes.

Authors:  Ahmed M Elsharkawy; Fiona Oakley; Feng Lin; Graham Packham; Derek A Mann; Jelena Mann
Journal:  J Hepatol       Date:  2010-06-02       Impact factor: 25.083

10.  European bone mineral density loci are also associated with BMD in East-Asian populations.

Authors:  Unnur Styrkarsdottir; Bjarni V Halldorsson; Daniel F Gudbjartsson; Nelson L S Tang; Jung-Min Koh; Su-mei Xiao; Timothy C Y Kwok; Ghi Su Kim; Juliana C N Chan; Stacey Cherny; Seung Hun Lee; Anthony Kwok; Suzanne Ho; Solveig Gretarsdottir; Jelena Pop Kostic; Stefan Th Palsson; Gunnar Sigurdsson; Pak C Sham; Beom-Jun Kim; Annie W C Kung; Shin-Yoon Kim; Jean Woo; Ping-C Leung; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

View more
  29 in total

Review 1.  Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.

Authors:  Jonathan A R Gordon; Janet L Stein; Jennifer J Westendorf; Andre J van Wijnen
Journal:  Bone       Date:  2015-03-31       Impact factor: 4.398

Review 2.  Epigenetic pathways regulating bone homeostasis: potential targeting for intervention of skeletal disorders.

Authors:  Jonathan A R Gordon; Martin A Montecino; Rami I Aqeilan; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Curr Osteoporos Rep       Date:  2014-12       Impact factor: 5.096

3.  Peripheral blood-derived mesenchymal stem cells: candidate cells responsible for healing critical-sized calvarial bone defects.

Authors:  Shaowei Li; Ke-Jung Huang; Jen-Chieh Wu; Michael S Hu; Mrinmoy Sanyal; Min Hu; Michael T Longaker; H Peter Lorenz
Journal:  Stem Cells Transl Med       Date:  2015-03-05       Impact factor: 6.940

4.  Plant homeodomain finger protein 2 promotes bone formation by demethylating and activating Runx2 for osteoblast differentiation.

Authors:  Hye-Jin Kim; Jong-Wan Park; Kyoung-Hwa Lee; Haejin Yoon; Dong Hoon Shin; Uk-Il Ju; Seung Hyeok Seok; Seung Hyeon Lim; Zang Hee Lee; Hong-Hee Kim; Yang-Sook Chun
Journal:  Cell Res       Date:  2014-09-26       Impact factor: 25.617

5.  Regulation of Bone Metabolism.

Authors:  Maryam Shahi; Amir Peymani; Mehdi Sahmani
Journal:  Rep Biochem Mol Biol       Date:  2017-04

Review 6.  Epigenetic regulation of bone cells.

Authors:  Kyung Hyun Park-Min
Journal:  Connect Tissue Res       Date:  2016-04-14       Impact factor: 3.417

Review 7.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

Review 8.  The Spectrum of Fundamental Basic Science Discoveries Contributing to Organismal Aging.

Authors:  Joshua N Farr; Maria Almeida
Journal:  J Bone Miner Res       Date:  2018-08-13       Impact factor: 6.741

Review 9.  Genetic and molecular control of osterix in skeletal formation.

Authors:  Krishna M Sinha; Xin Zhou
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

10.  Hdac3 Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteochondroprogenitor Cells.

Authors:  Meghan E McGee-Lawrence; Lomeli R Carpio; Ryan J Schulze; Jessica L Pierce; Mark A McNiven; Joshua N Farr; Sundeep Khosla; Merry Jo Oursler; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2015-08-20       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.